At least 20 countries have approved the inoculation for use, including European Union member-state Hungary, while key markets such as Brazil and India are close to authorizing it. Now Russia is setting its sights on the prized EU market as the bloc struggles with its vaccination program amid supply shortages.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2MXw3Tr
via IFTTT
0 comments:
Post a Comment